RT Journal Article
SR Electronic
T1 The pharmacological treatment of acquired nystagmus
JF Practical Neurology
JO Pract Neurol
FD BMJ Publishing Group Ltd
SP 147
OP 153
DO 10.1136/practneurol-2011-000181
VO 12
IS 3
A1 Mehta, Arpan R
A1 Kennard, Christopher
YR 2012
UL http://pn.bmj.com/content/12/3/147.abstract
AB We review the latest literature on the neuropharmacological treatments for acquired nystagmus. Nystagmus may have a significantly impact on health, yet there is little scientific evidence on which to make firm recommendations for treatment. Acquired pendular nystagmus may respond to gabapentin or memantine; downbeat and upbeat nystagmus to aminopyridines; and periodic alternating nystagmus to baclofen. To improve treatment we need multi-centre, randomised controlled trials using standardised techniques in reporting objective outcomes, with good follow-up duration and careful reporting of side effects.